Dachaigh › Purpura Thrombocytopenic Idiopathic
Sgrùdaidhean clionaigeach Purpura Thrombocytopenic Idiopathic a’ fastadh anns na SA
Tha 17 sgrùdaidhean airson Purpura Thrombocytopenic Idiopathic a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Los Angeles, CA7 sgrùdaidhean
- Washington, DC6 sgrùdaidhean
- Greenville, NC6 sgrùdaidhean
- Boston, MA6 sgrùdaidhean
- The Bronx, NY5 sgrùdaidhean
- Durham, NC4 sgrùdaidhean
- Rochester, MN4 sgrùdaidhean
- Seattle, WA4 sgrùdaidhean
- Houston, TX4 sgrùdaidhean
- Portland, OR4 sgrùdaidhean
- New Orleans, LA3 sgrùdaidhean
- New Haven, CT3 sgrùdaidhean
- Cedar Rapids, IA3 sgrùdaidhean
- Cleveland, OH3 sgrùdaidhean
- Kansas City, MO3 sgrùdaidhean
- Philadelphia, PA3 sgrùdaidhean
Le stàit
- Arkansas3 sgrùdaidhean
- California10 sgrùdaidhean
- Connecticut3 sgrùdaidhean
- Florida3 sgrùdaidhean
- Illinois4 sgrùdaidhean
- Iowa3 sgrùdaidhean
- Louisiana4 sgrùdaidhean
- Massachusetts6 sgrùdaidhean
- Michigan3 sgrùdaidhean
- Minnesota5 sgrùdaidhean
- Missouri3 sgrùdaidhean
- New Jersey4 sgrùdaidhean
- New York7 sgrùdaidhean
- North Carolina7 sgrùdaidhean
- Ohio3 sgrùdaidhean
- Oregon4 sgrùdaidhean
- Pennsylvania3 sgrùdaidhean
- Sgìre Cholumbia6 sgrùdaidhean
- Texas4 sgrùdaidhean
- Virginia4 sgrùdaidhean
- Washington4 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07421167A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07786077A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06721013Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07549698A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06722235A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
A’ fastadhÌre 3
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07700238Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07095127Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07104565A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
A’ fastadhÌre 3
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06948318OM336 in Autoimmune Cytopenias
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07083960Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
A’ fastadhÌre 1
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06371417Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT07007962Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 12 Cèit 2026 · NCT05070845A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Cèit 2026 · NCT06544499Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
A’ fastadhÌre 1
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT04323748Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Gearr 2025 · NCT06817395Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.